English | Español
Katelyn Kivel | Dec 28, 2015

Toronto Stock Exchange investigates Response Biomedical listing, details renewed eligibility requirements
+ Regulatory
Daniel Daw | Dec 27, 2015

FDA allows inactive gay men to provide blood donations
+ Community
Jamie Barrand | Dec 27, 2015

Texas Tech's accelerated family practice program offers med students affordable alternative
+ Community
Jamie Barrand | Dec 27, 2015

Freddie Mac, Easter Seals partner to help veterans, seniors find affordable housing
+ Technology/Innovation
Jamie Barrand | Dec 27, 2015

PhRMA blog features diabetes researchers answering medication-related questions
+ Technology/Innovation
Jamie Barrand | Dec 27, 2015

FDA lifts warning labels on diabetes drugs containing rosiglitazone
+ Regulatory
Jamie Barrand | Dec 27, 2015

Congress spending bill includes $264 billion funding increase for cancer research
+ Technology/Innovation
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation